News & Analysis on Clinical Trial Services & Contract Research And Development
New analysis into the gene therapy market reveals that toxicological complications and poor therapy efficacy have hampered the growth of this sector in which new ways must be found to improve clinical efficiency and generate revenue.
A recent report has identified the need for effective clinical investigator recruitment, which has become so crucial in the laboratory management of successful clinical trials and subsequent product launches.
Pharmaceutical company, Takeda, has struck a deal with pharmaceutical services provider, PPD, in which it has acquired the rights to all dipeptidyl peptidase IV (DPP4) inhibitors - one of a new generation of agents for diabetes treatment.